Intrathecal Administration of scAAV9/JeT-GAN for the Treatment of Giant Axonal Neuropathy
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02362438 |
Recruitment Status :
Active, not recruiting
First Posted : February 13, 2015
Last Update Posted : November 21, 2023
|
Sponsor:
Taysha Gene Therapies, Inc.
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by (Responsible Party):
Taysha Gene Therapies, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | June 30, 2030 |
Estimated Study Completion Date : | April 1, 2035 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):